heart disease
Spotlight on Lp(a) Risks, Low Testing Prevalence, and Potential Treatments at Cardiology Meeting
Premium
At ACC's annual meeting, there was a big focus on educating doctors about Lp(a) testing and its role in heart disease as new drugs advance in clinical trials.
Study Identifies Six Biomarkers for Cardiovascular Disease Risk Among Rheumatoid Arthritis Patients
Premium
The six circulating analytes correlate with arterial inflammation and may identify people with heightened risk of cardiovascular disease.
Silence Therapeutics Looks to Raise $120M in Oversubscribed Private Placement
The firm will use the proceeds to advance its pipeline products, such as zerlasiran in people with elevated Lp(a) at high risk of cardiovascular events.
Polygenic Risk Score, AI Tool May Help Patients Reduce Inherited Heart Disease Risk, Study Suggests
Premium
University of Cambridge researchers said at the American College of Cardiology annual meeting that they plan to make the PRS and AI tool publicly available through an online app.
The firm uses epigenetic and genetic information, along with machine learning to determine a patient's risk of cardiovascular disease.